ofloxacin and pipemidic acid

ofloxacin has been researched along with pipemidic acid in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-199025 (80.65)18.7374
1990's1 (3.23)18.2507
2000's4 (12.90)29.6817
2010's1 (3.23)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Domagala, JM; Hanna, LD; Heifetz, CL; Hutt, MP; Mich, TF; Sanchez, JP; Solomon, M1
Cecchetti, V; Fravolini, A; Fringuelli, R; Mascellani, G; Pagella, P; Palmioli, M; Segre, G; Terni, P1
Antón-Fos, GM; Duart, MJ; Mut-Ronda, S; Salabert-Salvador, MT1
Hashida, Y; Konaka, R; Kourai, H; Maseda, H; Shirai, A1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Barnett, G; Carbó, M; de la Torre, R; Segura, J1
Nishino, T; Obana, Y1
Harder, S; Papenburg, A; Staib, AH; Stille, W1
Beer, C; Harder, S; Papenburg, A; Shah, PM; Staib, AH; Stille, W1
Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL2
Cremer, AW; Felmingham, D; Grüneberg, RN; O'Hare, MD; Ridgway, GL; Robbins, MJ; Wall, RA; Williams, AH1
Grimm, H2
Forth, W1
Baldinelli, L; De Santis, S; De Simone, C; Ferrazzi, M; Pugnaloni, L; Sorice, F1
Cancet, B; Clave, D; Didier, J; Henry-Ferry, S; Marty, N1
Concia, E; Cruciani, M; Monzillo, V; Navarra, A; Tinelli, C1
Daguet, GL; Delisle-Mizon, F; Lesage, D; Vergez, P1
Allocati, N; Cellini, L; Di Girolamo, A; Piccolomini, R; Scazzocchio, F; Selan, L1
Guenounou, M; Kodari, E; Momrikof, V; Ronco, E; Vacheron, F1
Hirose, T; Inoue, M; Ito, Y; Kato, H; Mitsuhashi, S; Okezaki, E1
Kawane, H; Niki, Y; Soejima, R; Sumi, M; Umeki, S1
Wittenberger, R1
Smith, JT1
Bryskier, A; Husson, MO; Izard, D; Leclerc, H1
Klesel, N; Limbert, M; Seibert, G1
Deguchi, K; Fujita, Y; Kishi, H; Niijima, T; Nishimura, Y; Nito, H; Ogawa, N; Ohmori, H; Saito, I; Tanaka, H1
Ito, K; Konishi, K; Kosugi, M; Matsubara, Y; Matsunaga, M; Saito, M; Seo, T; Takizawa, Y; Tomizawa, I; Yanagishita, T1
Duan, GC; Xi, YL; Zhu, JY1
Depta, JP; Pichler, WJ; Schmid, DA1

Trials

4 trial(s) available for ofloxacin and pipemidic acid

ArticleYear
4-quinolones inhibit biotransformation of caffeine.
    European journal of clinical pharmacology, 1988, Volume: 35, Issue:6

    Topics: Adult; Biotransformation; Caffeine; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Interactions; Enoxacin; Humans; Male; Molecular Structure; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones; Random Allocation; Theophylline

1988
[Ofloxacin versus pipemidic acid and co-trimoxazole].
    Infection, 1986, Volume: 14 Suppl 1

    Topics: Adult; Anti-Infective Agents, Urinary; Bacteria; Bacterial Infections; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Humans; Nicotinic Acids; Ofloxacin; Oxazines; Pipemidic Acid; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

1986
[Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
    Hinyokika kiyo. Acta urologica Japonica, 1984, Volume: 30, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Clinical Trials as Topic; Double-Blind Method; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Nicotinic Acids; Ofloxacin; Oxazines; Pipemidic Acid; Tablets; Urinary Tract Infections

1984
[Comparison of clinical efficacy of ofloxacin COFLX: DL-8280) and pipemidic acid (PPA) in acute infectious diarrhea by a double-blind method. The Japan Research Committee of Ofloxacin, Research Group for Acute Infectious Diarrhea].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1984, Volume: 58, Issue:10

    Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Campylobacter Infections; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Dysentery, Bacillary; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Nicotinic Acids; Ofloxacin; Oxazines; Pipemidic Acid

1984

Other Studies

27 other study(ies) available for ofloxacin and pipemidic acid

ArticleYear
New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:3

    Topics: Anti-Bacterial Agents; Bacteria; DNA, Bacterial; DNA, Superhelical; Escherichia coli; Microbial Sensitivity Tests; Naphthyridines; Plasmids; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors

1986
Quinolonecarboxylic acids. 2. Synthesis and antibacterial evaluation of 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acids.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:3

    Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Pyridones; Spectrophotometry, Infrared; Thiazines

1987
Search compounds with antimicrobial activity by applying molecular topology to selected quinolones.
    Bioorganic & medicinal chemistry letters, 2003, Aug-18, Volume: 13, Issue:16

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Discriminant Analysis; Drug Design; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship; Quinolones

2003
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Cetylpyridinium; Disinfectants; Drug Resistance, Multiple, Bacterial; Membrane Proteins; Mutation; Norfloxacin; Quaternary Ammonium Compounds; Serratia marcescens

2009
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
    European journal of clinical pharmacology, 1990, Volume: 39, Issue:1

    Topics: Caffeine; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Male; Models, Biological; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones

1990
In vivo activity of ciprofloxacin, ofloxacin, norfloxacin and pipemidic acid against Escherichia coli infections in mice.
    Drugs under experimental and clinical research, 1989, Volume: 15, Issue:2

    Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; Female; Mice; Microbial Sensitivity Tests; Neutropenia; Norfloxacin; Ofloxacin; Pipemidic Acid; Time Factors; Urinary Tract Infections; Uterus

1989
[Gyrase inhibitors modify metabolising processes in the liver].
    Deutsche medizinische Wochenschrift (1946), 1987, Oct-30, Volume: 112, Issue:44

    Topics: Caffeine; Ciprofloxacin; DNA Topoisomerases, Type II; Enoxacin; Humans; Liver; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Topoisomerase II Inhibitors

1987
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.
    Drugs under experimental and clinical research, 1985, Volume: 11, Issue:4

    Topics: 4-Quinolones; Aeromonas; Anti-Bacterial Agents; Anti-Infective Agents; Campylobacter fetus; Cinoxacin; Ciprofloxacin; Diarrhea; Enoxacin; Fluoroquinolones; Humans; In Vitro Techniques; Intestines; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Salmonella; Shigella; Vibrio cholerae; Vibrio parahaemolyticus; Yersinia enterocolitica

1985
The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Drugs under experimental and clinical research, 1985, Volume: 11, Issue:4

    Topics: 4-Quinolones; Anti-Infective Agents; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones; Streptococcus pneumoniae

1985
Comparative in vitro studies with 4-quinolone antimicrobials.
    Drugs under experimental and clinical research, 1985, Volume: 11, Issue:5

    Topics: 4-Quinolones; Anti-Infective Agents; Bacteria; Cinoxacin; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Quinolines; Quinolizines; Quinolones

1985
[In vitro activity of seven gyrase inhibitors of a group of heterocyclic carbonic acids against nonfermenting gram negative rods (nonfermenters)].
    Arzneimittel-Forschung, 1985, Volume: 35, Issue:3

    Topics: Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Pseudomonas aeruginosa; Quinolines; Topoisomerase II Inhibitors

1985
[Gyrase inhibitor].
    Klinische Wochenschrift, 1985, Oct-01, Volume: 63, Issue:19

    Topics: 4-Quinolones; Anti-Bacterial Agents; Bacteria; Cinoxacin; Drug Resistance, Microbial; Humans; Nalidixic Acid; Ofloxacin; Oxazines; Pipemidic Acid; Quinolines; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors

1985
Influence of ofloxacin, norfloxacin, nalidixic acid, pyromidic acid and pipemidic acid on human gamma-interferon production and blastogenesis.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 17, Issue:6

    Topics: Adult; Anti-Infective Agents; DNA; Humans; In Vitro Techniques; Interferon-gamma; Lymphocyte Activation; Lymphocytes; Male; Middle Aged; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Piromidic Acid

1986
[In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].
    Infection, 1986, Volume: 14 Suppl 3

    Topics: Acinetobacter; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Gram-Negative Bacteria; Immunodiffusion; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Pseudomonas

1986
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
    Pathologie-biologie, 1988, Volume: 36, Issue:5

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Enoxacin; Female; Humans; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Peptides, Cyclic; Pipemidic Acid; Rifampin; Tetracycline; Tetracycline Resistance; Urinary Tract Infections; Vancomycin; Virginiamycin

1988
Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers.
    Drugs under experimental and clinical research, 1988, Volume: 14, Issue:8

    Topics: Adult; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella; Male; Nicotinic Acids; Norfloxacin; Ofloxacin; Pipemidic Acid; Proteus mirabilis; Pseudomonas aeruginosa; Time Factors

1988
[Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
    Pathologie-biologie, 1985, Volume: 33, Issue:5

    Topics: Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pefloxacin; Pipemidic Acid; Pseudomonas; Pseudomonas aeruginosa; Quinolines

1985
In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1988, Volume: 7, Issue:5

    Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Pefloxacin; Pipemidic Acid; Proteus; Providencia; Urinary Tract Infections

1988
[Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production].
    Pathologie-biologie, 1987, Volume: 35, Issue:5 Pt 2

    Topics: Animals; Anti-Infective Agents; Cell Division; Cells, Cultured; Ciprofloxacin; Interleukin-1; Macrophages; Male; Mice; Mice, Inbred DBA; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Spleen

1987
In vitro and in vivo activity of NY-198, a new difluorinated quinolone.
    Antimicrobial agents and chemotherapy, 1987, Volume: 31, Issue:6

    Topics: Animals; Anti-Infective Agents; Bacterial Infections; Fluoroquinolones; Male; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Quinolines; Quinolones

1987
New synthetic quinolone antibacterial agents and serum concentration of theophylline.
    Chest, 1987, Volume: 92, Issue:4

    Topics: Adult; Anti-Infective Agents; Chemical Phenomena; Chemistry; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid; Theophylline

1987
Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Scandinavian journal of infectious diseases. Supplementum, 1986, Volume: 49

    Topics: 4-Quinolones; Anti-Bacterial Agents; Cinoxacin; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Escherichia coli; Fluoroquinolones; Mutation; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Pipemidic Acid; Quinolines; Quinolizines; Quinolones

1986
Ofloxacin: antibacterial activity, induction of resistance and killing curves.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1985, Volume: 4, Issue:4

    Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pipemidic Acid

1985
Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.
    European journal of clinical microbiology, 1983, Volume: 2, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Drug Resistance, Microbial; Lactams; Mice; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid

1983
[Study on the molecular mechanism of quinolone resistance in Shigellae spp].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 2004, Volume: 25, Issue:3

    Topics: Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Pipemidic Acid; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Quinolones; Shigella

2004
T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2006, Volume: 36, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigen-Presenting Cells; Aza Compounds; Cell Proliferation; Cells, Cultured; Ciprofloxacin; Clone Cells; Cross Reactions; Drug Hypersensitivity; Enoxacin; Female; Fluoroquinolones; Humans; Hypersensitivity, Delayed; Middle Aged; Moxifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Patch Tests; Pipemidic Acid; Quinolines; Quinolones; T-Lymphocytes

2006